Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Louis J. Denis
Observed names:
Denis, L.J,
Louis Denis
Institution:
Verastem (United States)
Observed institutions:
Vrije Universiteit Brussel,
ZNA Middelheim Hospital,
Verastem (United States)
OpenAlex ID:
A5086856559
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach
2015
·
Alicia K. Morgans
, Annelotte C.M. van Bommel
, et al.
·
European Urology
·
120
PDF
Quality of life in patients with prostatic cancer a feasibility study
1993
·
F. Calais Da Silva
, Elizabeth Reis
, et al.
·
Cancer
·
78
The role of active treatment in early prostate cancer
2000
·
Louis J. Denis
·
Radiotherapy and Oncology
·
36
Prostate Cancer
2007
·
Ramon, J
, Denis, L.J
·
Recent results in cancer research/Recent Results in Cancer Research
·
29
Single Agent VS-6766 or VS-6766 Plus Defactinib in KRAS -Mutant Non-Small-Cell Lung Cancer: The RAMP-202 Phase II Trial
2022
·
Enrica Capelletto
, Paolo Bironzo
, et al.
·
Future Oncology
·
28
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences
2001
·
Laurence Collette
, Urs E. Studer
, et al.
·
The Prostate
·
28
Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot lhrh analogue
1991
·
Charles Mahler
, Johan Verhelst
, et al.
·
Cancer
·
24
PDF
Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205).
2024
·
Kian-Huat Lim
, Kristen Renee Spencer
, et al.
·
Journal of Clinical Oncology
·
17
PDF
Europa Uomo: The European Prostate Cancer Coalition
2007
·
Tom Hudson
, Louis J. Denis
·
Springer eBooks
·
12
Letter to the Editor
1996
·
Louis J. Denis
·
The Prostate
·
11
ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).
2022
·
Susana N. Banerjee
, Bradley J. Monk
, et al.
·
Journal of Clinical Oncology
·
10
RAMP 202: A phase 2 study of avutometinib (VS-6766) ± defactinib, in patients with advanced KRAS G12V mutant non–small cell lung cancer (NSCLC).
2023
·
Joshua E. Reuss
, Sunil G. Gandhi
, et al.
·
Journal of Clinical Oncology
·
8
Tumor, nodes, metastasis (TNM) classification of bladder cancer
1998
·
Jerome P. Richie
, Aldo Bono
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
6
A phase 2 study of VS-6766 (RAF/MEK clamp) RAMP 202, as a single agent and in combination with defactinib (FAK inhibitor) in recurrent KRAS mutant (mt) and BRAF mt non–small cell lung cancer (NSCLC).
2022
·
D. Ross Camidge
, Joshua E. Reuss
, et al.
·
Journal of Clinical Oncology
·
4
A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non–small cell lung cancer (NSCLC) (RAMP 203).
2022
·
Ramaswamy Govindan
, Mark M. Awad
, et al.
·
Journal of Clinical Oncology
·
4
The Medical Management of Prostate Cancer
1988
·
Louis Denis
·
Springer eBooks
·
4
A phase III, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of therapy among patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-OV81/NCRI/RAMP 301
2024
·
Rachel Grisham
, Bradley Monk
, et al.
·
Gynecologic Oncology
·
3
Abstract CT204: A phase 1/2 study of VS-6766 in combination with sotorasib in patients with KRAS G12C mutant non-small cell lung cancer (NSCLC) (RAMP 203)
2022
·
Ramaswamy Govindan
, Jonathan A. Pachter
, et al.
·
Cancer Research
·
2
Abstract C003: RAMP 205: A phase 1b/2a study of gemcitabine, nab-paclitaxel, avutometinib, and defactinib in untreated metastatic pancreatic ductal adenocarcinoma
2024
·
Kian-Haut Lim
, Manuel Hidalgo
, et al.
·
Cancer Research
Show more works
View as search
Works count:
19
Citation count:
424
H-index:
10
I10-index:
11
Year
Topic
Type